6Delori FC, Dorey CK, Staurenghi G, et al.In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics[J].Invest Ophthalmol Vis Sci, 1995, 36: 718-729.
7Bui TV, Han Y, Radu RA, et al.Characterization of native retinal fluorophores involved in biosynthesis of A2E and lipofuscin-associated retinopathies[J].J Biol Chem, 2006, 281 ( 26 ) : 18112-18119.
9Delori FC, Douglas G, Gogerand CK.Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects [J].Invest Ophtbalmol Vis Sci, 2001, 42( 8 ) : 1855-1866.
10Delori FC.Autofluorescence method to measure macular pigment optical densities fluorometry and autofluorescence imaging [J].Arch Biochem Biophys, 2004, 430(2): 156-162.
4Krauss TC, Warlen SC. The forensic science use of reflective ultraviolet photography. J Forensic Sci, 1985,30:262-268.
5Delori C, Fleckner MR, Goger DG, et al. Autofluorescence distribution associated with drusen in age-related macular degeneration. Invest Ophthalmol Vis Sci ,2000,41:496-504.
6Boulton M, Docchio F, Dayhaw-Barker P, et aL Age-related changes in the morphology, absorption and fluorescence of melanosomes and lipofuscin granules of the retinal pigment epithelium. Vision Res, 1990,30 : 1291-1303.
7Dorey Ck,Wu G,Ebenstein D,et al. Cell loss in the aging retina: relationship to lipofuscin accumulation and macular degeneration. Invest Ophthalmol Vis Sci,1989,30:1691-1699.
9Bui TV, Han Y, Radu RA, et al. Characterization of native retinal fluorophores involved in biosynthesis of A2E and lipofuscinassociated retinopathesis. J Biol Chem,2006,281 : 18112-18119.
10Mata NL, Weng J, Travis GH. Biosynthesis of a major lipofuscin fluorophores in mice and humans with ABCR-mediated retinal and macular degeneration. Proc Nail Acad Sci USA, 2000,97 : 7154- 7159.
2Samantha S. Dandekar,Sharon A. Jenkins,Tunde Peto,Hendrik P. N.Scholl,Kulwant S. Sehmi,Fred W. Fitzke,Alan C. Bird,Andrew R. Webster,李越（译）,惠延年（校）.年龄相关性黄斑变性产生的脉络膜新生血管自发荧光成像[J].美国医学会眼科杂志（中文版）,2006,18(3):139-145. 被引量：1
3American Academy of Ophthalmology Retina Panel.Preferred Practice Pattern@Guidelindes:age-related macular degeneration EB/OL I.San Francisco,CA:Ameriean Academy of Ophthalmology (AAO),2008.
4Schmidt-Erfurth UM,Richard G,Augustin A,et al.Guidance for the treatment of neovascuiar age-related macular degeneration.Acta Ophthalmol Scand,2007,85 (5):486-494.
5Age-Related Eye Disease Study Research Group.A randomized,placebo-controlled,clinical trial of high-dose supplementation with vitamins C and E,beta carotene,and zinc for age-related macular degeneration and vision loss:AREDS report no 8.Arch Ophthalmol,2001,119(10):1417-1436.
8Yoneyama S,Sakurada Y,Mabuchi F.Genetic and clinical factors associated with reticular pseudodrusen in exudative age-related maculardegeneration.Graefes Arch Clin Exp Ophthalmol,2014,252(9):1435-1441.
9Smith W,Assink J,Klein R,et al.Risk factors for age-related macular degeneration:pooled findings from three continents.Ophthalmology,2001,108(4):697-704.
10The Eye Diseases Prevalence Research Group.Prevalence of agerelated macular degeneration in the United States.Arch Ophthalmol,2004,122(4):564-572.
